"Designing Growth Strategies is in our DNA"

U.S. Joint Pain Injections Market Size, Share & Industry Analysis, By Product (Corticosteroid Injections, Hyaluronic Acid Injections, Platelet Rich Plasma Injections, and Others), By Joint Type (Knee, Hip, Hand & Wrist, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2025-2032

Last Updated: December 04, 2025 | Format: PDF | Report ID: FBI108119

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Epidemiology & Prevalence of Key Disorders, U.S.
    2. Overview of Advancements in Treatment of Osteoarthritis (OA)
    3. New Product Launches, By Key Players
    4. Key Industry Developments - Mergers, Acquisitions & Partnerships
    5. Impact of COVID-19 on the Market
  5. U.S. Joint Pain Injections Market Analysis, Insights and Forecast, 2019-2032 
    1. Market Analysis, Insights and Forecast – By Product 
      1. Corticosteroid Injections
      2. HA Injections
      3. PRP Injections
      4. Others 
    2. Market Analysis, Insights and Forecast – By Joint Type
      1. Knee
      2. Hip
      3. Hand & Wrist
      4. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel 
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies 
  6. Competitive Analysis 
    1. U.S. Market Share Analysis (2024)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Sanofi 
      2. Teva Pharmaceutical Industries Ltd.
      3. Dr. Reddy’s Laboratories Ltd.
      4. Zimmer Biomet
      5. Anika Therapeutics, Inc.
      6. Ferring
      7. Bioventus Inc.
      8. SEIKAGAKU CORPORATION
      9. Pacira Pharmaceuticals, Inc.
      10. Fidia Farmaceutici S.p.A.
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Epidemiology & Prevalence of Key Disorders, U.S.
    2. Overview of Advancements in Treatment of Osteoarthritis (OA)
    3. New Product Launches, By Key Players
    4. Key Industry Developments - Mergers, Acquisitions & Partnerships
    5. Impact of COVID-19 on the Market
  5. U.S. Joint Pain Injections Market Analysis, Insights and Forecast, 2019-2032 
    1. Market Analysis, Insights and Forecast – By Product 
      1. Corticosteroid Injections
      2. HA Injections
      3. PRP Injections
      4. Others 
    2. Market Analysis, Insights and Forecast – By Joint Type
      1. Knee
      2. Hip
      3. Hand & Wrist
      4. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel 
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies 
  6. Competitive Analysis 
    1. U.S. Market Share Analysis (2024)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Sanofi 
      2. Teva Pharmaceutical Industries Ltd.
      3. Dr. Reddy’s Laboratories Ltd.
      4. Zimmer Biomet
      5. Anika Therapeutics, Inc.
      6. Ferring
      7. Bioventus Inc.
      8. SEIKAGAKU CORPORATION
      9. Pacira Pharmaceuticals, Inc.
      10. Fidia Farmaceutici S.p.A.
Read Less

Table 01: U.S. Joint Pain Injections Market Revenue (USD billion) Forecast, By Product, 2019–2032

Table 02: U.S. Joint Pain Injections Market Revenue (USD billion) Forecast, By Joint Type, 2019–2032

Table 03: U.S. Joint Pain Injections Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Figure 01: U.S. Joint Pain Injections Market Revenue Breakdown (USD billion, %) by Product, 2024 & 2032

Figure 02: U.S. Joint Pain Injections Market Value Share (%), By Product, 2024 & 2032

Figure 03: U.S. Joint Pain Injections Market Value Share (%), By Joint Type, 2024 & 2032

Figure 04: U.S. Joint Pain Injections Market Value Share (%), By Distribution Channel, 2024 & 2032

Figure 05: U.S. Joint Pain Injections Market Share (%), 2024

U.S. Joint Pain Injections Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 101
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports